@FiercePharma: Surprise Provenge shortfall triggers Dendreon layoffs. Story | Follow @FiercePharma
> The European Society of Cardiology will review its atrial fibrillation treatment guidelines in light of a recently halted Multaq trial that raised safety questions about using the Sanofi drug in patients with permanent AF. Report
> An Abbott Laboratories plant in Temecula, CA, is the first business to be admitted to a foreign trade zone with boundaries recently redrawn to help area companies. Item
> Roche plans to sell its 256-employee manufacturing plant in Boulder, CO, to International Chemical Investors Group for use by the company's Corden Pharma group. Story
> Enzon Pharmaceuticals posted a larger quarterly loss as royalties from its hepatitis C drug Pegintron dropped. News
> Aspen Pharmacare reportedly won 29% of a 485 million rand ($70 million) tender to supply the South African government with tuberculosis drugs. Article
> The cost of Medicare Part D is dropping, with beneficiaries paying an average of $30 per month for a plan. Piece
Biotech News
@FierceBiotech: Be the first to meet the 2011 Fierce 15. News | Follow @FierceBiotech
@JohnCFierce: Texas Gov. Rick Perry gets a stem cell treatment, then lobbies for the procedure. Article | Follow @JohnCFierce
@MaureenFierce: 104-year-old 'super ager' can thank her lucky genes. Article | Follow @MaureenFierce
> Takeda, Amylin pull plug on obesity trial. News
> Questionable timing: House pushes biotech tax breaks. Article
> Dendreon releases death-eaters into biotech sector stocks. Report
And Finally... Japanese scientists make working mouse sperm from embryonic stem cells. More